New Core Collaboration: Flow Cytometry-MassNano & Precision RNA Medicine

We are pleased to announce a new collaboration between the Flow Cytometry-MassNano Facility and the Precision RNA Medicine Core at BIDMC.

This partnership integrates advanced nanoparticle characterization capabilities with lipid nanoparticle (LNP) formulation and production expertise, enabling researchers to comprehensively evaluate nanoparticle size, structure, composition, and functional performance within a coordinated workflow.

Through this collaboration, investigators working with RNA therapeutics and LNP-based delivery systems can now access both formulation development and high-resolution physicochemical characterization across the two cores.

Investigators interested in LNP development or nanoparticle characterization are encouraged to contact either core to discuss project design and available services.